Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.
about
Current management and perspectives for HCV recurrence after liver transplantationPre- and Post-Transplant Antiviral Therapy (HBV, HCV)Role of liver transplantation in human immunodeficiency virus positive patientsInterferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug ResistanceManagement of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewHepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementTreatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos inΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationChallenges of recurrent hepatitis C in the liver transplant patientFibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantationHuman monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesFeasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus sheddingIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Management of recurrent hepatitis C following liver transplantation.Antiviral treatment for hepatitis C virus infection after liver transplantation.Management of recurrent hepatitis C virus after liver transplantation.Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantationManagement of viral hepatitis in liver transplant recipientsMajor challenges limiting liver transplantation in the United States.Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant.Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.Liver transplantation in adults: Choosing the appropriate timingUse of Hepatitis C-Positive Donor Livers in Liver Transplantation.Hepatitis C genotype influences post-liver transplant outcomesRandomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virusTelaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.New perspectives for preventing hepatitis C virus liver graft infection.Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.Treatment of chronic hepatitis C in hemodialysis patients.
P2860
Q22299427-6569508D-839F-4F53-B35D-525CADF57DB8Q26740319-8337D52C-3C9C-458F-8577-9C5B160DA481Q26775931-1BCAB446-8BAA-4D94-97EA-1EE79F681BADQ26781331-0D6E4874-8440-408E-B518-7E4FBED42DF5Q26781741-E78881E5-A4CC-4831-8668-9E635E4F3F29Q26781984-E299D378-84E4-49F9-8B0E-39538034E02FQ26820811-3A757586-7B03-489A-97DF-DCB12BA7C4D6Q26864647-1737DA11-71E1-4D6D-8E72-A2067F7156B5Q27011871-E8F53075-06C2-4A9F-A3AD-2B01EF57618EQ28076406-9F9026A5-7B3A-4106-8BC1-76D1A6BA4F4AQ28483065-5993391E-162F-45D1-A274-33ADD2CA7386Q28535042-3FFC1D86-D5BF-401D-81B9-9DEE03D797CDQ30355190-1F0DAC55-DBB1-4847-807B-3449B92EA70DQ30374356-5669EDAE-FD6A-498A-969F-28DC90E95294Q30375305-C38304D6-BA27-4952-91AD-8C1FB301B759Q30417045-70F55191-E416-43B8-9C86-E45DF24B79DCQ33426112-47F8FDF0-9FD2-4043-8407-AE11453797DAQ34093754-C0550F0E-C95F-497C-8B61-BC274B160043Q34298333-DFE95C4B-8047-4687-A3C8-B01A885C5FA9Q34340293-80030D93-68DB-43BF-88C7-0AA87A9DC4B0Q34589655-0EC9D0EC-A071-4234-9AE0-D3611184E7A6Q34625761-018BB0D3-D316-4BC3-8AE3-1EE72B4FD420Q34779730-24D75B32-C060-43B3-9C99-EC51F90FF45CQ35194675-D846327A-BAE2-4686-BD60-A29D70617067Q35214724-6BE68C17-AF40-45DB-A2C5-6EFED3F521DDQ35384561-0E36DF61-733D-4AC6-B4FA-5AC002087F07Q35626794-8E530A39-6A48-4CE5-B67B-1283464B1177Q35790393-4D26A563-B3E5-4CC6-8035-8EE43548B5B5Q35808230-C906B4EF-D1BA-449C-9C6B-E7AF8E5BB68DQ36220176-80B37AB6-E3AF-47D8-91F6-EBA961A0FFB9Q36292616-C240DF6F-CB9D-4F0D-AF55-5C95DC29D944Q36354472-E1695687-0EC9-4274-A955-D228E27B6D1CQ36382719-7CEE808C-2F70-4AF9-B261-82662620470FQ36650834-307A3295-B066-41F2-8986-49D37E4845E7Q36760075-630BCAF1-CBBA-4097-A14D-DA36B59C8F77Q36855565-19DF3DDE-E715-4DAA-BF4C-658E82E1D5A2Q36997118-17CFFD5A-C12B-495E-A2A4-9A55B36862A2Q37015805-591DD0D6-C2CF-45D3-A2FC-91113D465C6AQ37118828-956DEAB8-9602-4058-B3B8-519B10A25FEFQ37313163-56D71ABB-D2B1-4E75-88B1-4E2452BFA7D1
P2860
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of the treat ...... in combination with ribavirin.
@en
Systematic review of the treat ...... in combination with ribavirin.
@nl
type
label
Systematic review of the treat ...... in combination with ribavirin.
@en
Systematic review of the treat ...... in combination with ribavirin.
@nl
prefLabel
Systematic review of the treat ...... in combination with ribavirin.
@en
Systematic review of the treat ...... in combination with ribavirin.
@nl
P1476
Systematic review of the treat ...... in combination with ribavirin.
@en
P2093
Marina Berenguer
P304
P356
10.1016/J.JHEP.2008.05.002
P577
2008-05-22T00:00:00Z